NCT00000740View on ClinicalTrials.gov

Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 1993

Conditions
Pneumonia, Pneumocystis CariniiHIV Infections
Interventions
DRUG

Sitamaquine

Trial Locations (2)

21287

Johns Hopkins Adult AIDS CRS, Baltimore

46202

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000740 - Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects | Biotech Hunter | Biotech Hunter